Enquyst Technologies

Enquyst Technologies

Biotechnology, 600 Suffolk St, Lowell, , 1854, Massachusetts, United States, 1-10 Employees

enquyst.com

  • LinkedIn

phone no Phone Number: +15*********

Who is ENQUYST TECHNOLOGIES

Enquyst Technologies is on a quest to engineer next-generation biomanufacturing technology solutions to give the growing diversity of life changing and curative treatments a viable path t...

Read More

map
  • 600 Suffolk St, Lowell, Massachusetts, 1854, United States Headquarters: 600 Suffolk St, Lowell, Massachusetts, 1854, United States
  • 2017 Date Founded: 2017
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 3826 | NAICS Code: 334516 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ENQUYST TECHNOLOGIES

Enquyst Technologies Org Chart and Mapping

Employees

Brock Jacobites

Director of Hardware Engineering

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Enquyst Technologies

Answer: Enquyst Technologies's headquarters are located at 600 Suffolk St, Lowell, , 1854, Massachusetts, United States

Answer: Enquyst Technologies's phone number is +15*********

Answer: Enquyst Technologies's official website is https://enquyst.com

Answer: Enquyst Technologies's revenue is $25 Million to $50 Million

Answer: Enquyst Technologies's SIC: 3826

Answer: Enquyst Technologies's NAICS: 334516

Answer: Enquyst Technologies has 1-10 employees

Answer: Enquyst Technologies is in Biotechnology

Answer: Enquyst Technologies contact info: Phone number: +15********* Website: https://enquyst.com

Answer: Enquyst Technologies is on a quest to engineer next-generation biomanufacturing technology solutions to give the growing diversity of life changing and curative treatments a viable path to the clinic with affordable costs. The unprecedentedly high purity resulting from Enquysts patented, core IPP technology is expected to deliver a scalable solution for the purification of AAV and lentiviral vector-based gene therapies, enabling development and rapid growth of these markets.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access